Valuation: Biogen Inc.

Market Cap 2.83TCr 2.48TCr 2.29TCr 2.1TCr 3.98TCr 2,72700Cr 4.05TCr 27TCr 11TCr 1,33300Cr 11TCr 10TCr 4,59400Cr P/E 2026 *
22.8x
P/E 2027 * 15.4x
Enterprise Value 3.39TCr 2.96TCr 2.74TCr 2.51TCr 4.76TCr 3,26300Cr 4.85TCr 33TCr 13TCr 1,59500Cr 13TCr 12TCr 5,49700Cr EV / Sales 2026 *
3.36x
EV / Sales 2027 * 3.07x
Free-Float
85.96%
Yield 2026 *
-
Yield 2027 * -
1 day+2.76%
1 week-1.56%
Current month-8.71%
1 month-0.70%
3 months+9.25%
6 months+17.01%
Current year+12.07%
1 week 186.02
Extreme 186.025
210.87
1 month 186.02
Extreme 186.025
219.72
Current year 160.36
Extreme 160.3645
219.72
1 year 121.05
Extreme 121.05
219.72
3 years 110.04
Extreme 110.035
281.12
5 years 110.04
Extreme 110.035
351.86
10 years 110.04
Extreme 110.035
468.55
Manager TitleAgeSince
Chief Executive Officer 66 14/11/2022
Director of Finance/CFO 60 01/03/2025
Chief Tech/Sci/R&D Officer - 01/01/2021
Director TitleAgeSince
Director/Board Member 69 23/03/2010
Director/Board Member 77 01/01/2010
Director/Board Member 72 19/06/2019
Date Insider Type Main position Quantity % Market Cap.
09/06Free

Director

1,505 0.0010%
09/06Free

Chairman

2,005 0.0014%
09/06Fiscal year

Director

6,245 0.0042%
Change 5-day change 1-year change 3-year change Capi.($)
+2.76%-1.56%+54.70%-29.15% 2.83TCr
+1.27%+0.24%+21.26%-7.92% 6.68TCr
+1.38%-7.13%+36.60%+197.15% 5.06TCr
+1.10%+38.30%+38.30%+38.30% 4.25TCr
-0.98%-1.79%-49.61%-53.35% 4.12TCr
+1.25%-7.48%+116.21%-44.31% 2.68TCr
+0.18%-1.85%+68.63%+88.43% 2.3TCr
+7.77%+11.30%+18.35%+199.08% 2TCr
-1.70%+5.53%+76.00%+157.99% 1.65TCr
+0.44%-4.96%+54.37%+124.19% 1.63TCr
Average +1.34%-2.68%+43.48%+67.04% 3.32TCr
Weighted average by Cap. +1.23%-3.09%+34.95%+52.78%

Financials

2026 *2027 *
Net sales 1.01TCr 882.13Cr 813.75Cr 748.04Cr 1.42TCr 97TCr 1.44TCr 9.71TCr 3.81TCr 47TCr 3.79TCr 3.71TCr 1,63600Cr 1.04TCr 905.67Cr 835.46Cr 768Cr 1.46TCr 1LCr 1.48TCr 9.97TCr 3.91TCr 49TCr 3.89TCr 3.8TCr 1,67900Cr
Net income 136.21Cr 119.09Cr 109.86Cr 100.98Cr 191.34Cr 13TCr 194.61Cr 1.31TCr 514.6Cr 6.41TCr 511.52Cr 500.31Cr 22TCr 194.89Cr 170.39Cr 157.19Cr 144.49Cr 273.78Cr 19TCr 278.46Cr 1.88TCr 736.3Cr 9.17TCr 731.89Cr 715.85Cr 32TCr
Net Debt 557.18Cr 487.14Cr 449.38Cr 413.09Cr 782.71Cr 54TCr 796.1Cr 5.36TCr 2.11TCr 26TCr 2.09TCr 2.05TCr 90TCr 343.7Cr 300.5Cr 277.21Cr 254.82Cr 482.83Cr 33TCr 491.08Cr 3.31TCr 1.3TCr 16TCr 1.29TCr 1.26TCr 56TCr
Logo Biogen Inc.
Biogen Inc. is one of the world's leaders in the design, manufacturing, and marketing of therapeutic products. Net sales break down by source of income as follows: - sales of medicines (72%): for treating multiple sclerosis, chronic psoriasis in adults, rheumatoid arthritis, cancers, etc.; - royalties (7.4%) ; - other (20.6%): primarily revenues from partnership agreements.
Employees
7,500
Date Price Change Volume
16/26/16 $197.24 +2.76% 20,67,251
14/26/14 $191.95 -8.17% 39,02,309
13/26/13 $209.03 +4.96% 22,59,821
10/26/10 $199.15 +0.12% 11,33,120
09/26/09 $198.91 -0.72% 16,57,327
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
36
Last Close Price
191.95USD
Average target price
225.45USD
Spread / Average Target
+17.45%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BIIB Stock